tiprankstipranks

Jason Haas Insider Profile

11 Followers
Jason Haas, Director at Ligand Pharma, holds 3.98K shares in Ligand Pharma (Ticker: LGND), holds 62.91K shares in Odyssey Therapeutics, Inc. (Ticker: ODTX), holds 0.00 shares in Syros Pharmaceuticals (Ticker: SYRS).
tipranks
Jason Haas

Jason Haas
Ligand Pharma (LGND)
Director

Ranked #65,412 out of 108,921 Corporate Insiders

Profitable Transactions

50%
2 out of 4 Profitable Transactions

Average Return

-6.60%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$3M
59.60%
40.40%
0.00%
A breakdown of Jason Haas's holdings

Insider Roles

Odyssey Therapeutics, Inc.
(ODTX)
Chief Financial Officer
Ligand Pharma
(LGND)
Director
Syros Pharmaceuticals
(SYRS)
CFO
Roles that Jason Haas holds in companies

Most Profitable Insider Trade

Stock:
Odyssey Therapeutics, Inc.
(ODTX)
Rating:Informative Buy
Date:May 11, 2026 - Today
Return:+64.80%
The most profitable trade made by Jason Haas

Jason Haas's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Ligand Pharma
Aug 14, 2026
Director
Uninformative Buy
316.48K
$1.15M
Odyssey Therapeutics, Inc.
May 11, 2026
Chief Financial Officer
Informative Buy
20.00K
$1.70M
Syros Pharmaceuticals
Nov 20, 2024
CFO
Informative Sell
28.94K
List of latest transactions for each holding click on a transaction to see Jason Haas's performance on stock

Jason Haas insider profile FAQ

What is the percentage of profitable transactions made by Jason Haas?
The percentage of profitable transactions made by Jason Haas is 50%.
    What is the average return per transaction made by Jason Haas?
    The average return per transaction made by Jason Haas is -6.60%.
      What stocks does Jason Haas hold?
      Jason Haas holds: LGND, ODTX, SYRS stocks.
        What was Jason Haas’s latest transaction?
        Jason Haas latest transaction was an Uninformative Buy of $316.48K.
          What was Jason Haas's most profitable transaction?
          Jason Haas’s most profitable transaction was an Informative Buy of ODTX stock on May 11, 2026. The return on the trade was 64.80%.
            What is Jason Haas's role in Ligand Pharma?
            Jason Haas's role in Ligand Pharma is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.